BioCentury | Sep 10, 2020
Finance

Korro Bio’s $91.5M series A brings in new investors, launches hunt for CEO

...potential targets.The company is one of at least three pursuing therapeutic RNA editing. Last November, Shape Therapeutics Inc....
BioCentury | Nov 21, 2019
Emerging Company Profile

ShapeTx: Shaping up RNA editing

...guide that binds a target RNA sequence and recruits adenosine deaminases acting on RNA (ADARs), Shape Therapeutics Inc.’s...
BioCentury | Nov 7, 2019
Financial News

Nov. 6 Financial Quick Takes: NEA backs Shape's series A; plus Royalty-Eisai-Epizyme, Sinomed, Genecast and Cadence

...Shape raises $35.5M A round RNA editing company Shape Therapeutics Inc. raised $35.5 million in a series A...
BioCentury | Nov 6, 2019
Company News

Nov. 5 Company Quick Takes: Takeda licenses MD Anderson CAR NK cell portfolio; plus Myriad, Canbridge, BioCryst-Torii and Strongbridge

...HER4) (ErbB4) Epidermal growth factor receptor (EGFR) (ErbB1) (HER1) Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu) CD19 Kallikrein Shape Therapeutics Inc....
Items per page:
1 - 4 of 4
BioCentury | Sep 10, 2020
Finance

Korro Bio’s $91.5M series A brings in new investors, launches hunt for CEO

...potential targets.The company is one of at least three pursuing therapeutic RNA editing. Last November, Shape Therapeutics Inc....
BioCentury | Nov 21, 2019
Emerging Company Profile

ShapeTx: Shaping up RNA editing

...guide that binds a target RNA sequence and recruits adenosine deaminases acting on RNA (ADARs), Shape Therapeutics Inc.’s...
BioCentury | Nov 7, 2019
Financial News

Nov. 6 Financial Quick Takes: NEA backs Shape's series A; plus Royalty-Eisai-Epizyme, Sinomed, Genecast and Cadence

...Shape raises $35.5M A round RNA editing company Shape Therapeutics Inc. raised $35.5 million in a series A...
BioCentury | Nov 6, 2019
Company News

Nov. 5 Company Quick Takes: Takeda licenses MD Anderson CAR NK cell portfolio; plus Myriad, Canbridge, BioCryst-Torii and Strongbridge

...HER4) (ErbB4) Epidermal growth factor receptor (EGFR) (ErbB1) (HER1) Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu) CD19 Kallikrein Shape Therapeutics Inc....
Items per page:
1 - 4 of 4